Solli E, Bevilacqua A, Wenes M, Migliorini D, van der Veen L, Skånland SS, Di Conza G, Taskén K(2026) The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity Mol Oncol(in press) DOI 10.1002/1878-0261.70203, PubMed 41568714
Van der Pol H, Kringelbach T, Martin Agudo M, Bratseth Stav G, Fagereng GL, Fiocco M, Sørum Falk R, Homer V, Haj Mohammad S, Timmer H, Verlingue L, Helland Å, Rohrberg K, Lassen U, Halford S, Jalkanen K, Juslin T, Krebs MG, Oliveira J, Baltruskeviciene E, Ojamaa K, Taskén K, Gelderblom H(2026) Procedures of data merging in precision cancer medicine: the PRIME-ROSE project Acta Oncol, 65, 1-8 DOI 10.2340/1651-226X.2026.44889, PubMed 41496458
Myklebust J, Taskén K(2025) Nobelpris for regulatoriske T-celler og immuntoleranse Tidsskr Nor Laegeforen, 145(15) DOI 10.4045/tidsskr.25.0649, PubMed 41410971